Prescribing information for Canagliflozin can be found here.
This promotional webcast has been developed by Napp Pharmaceuticals Limited and Napp products will be discussed. The peer-reviewed publication discussed in this webcast was independently developed by the Improving Diabetes Steering Committee and the Committee remains independent from Napp in the delivery of their commentary on this peer-reviewed publication within this promotional webcast. Napp has fully funded the meeting and is responsible for the content, logistics and selection of speakers. OmniaMed has provided editorial, marketing and logistical support.